Myriam Anne Armant, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Scleral Diseases | 1 | 2022 | 22 | 0.780 |
Why?
|
Limbus Corneae | 2 | 2022 | 144 | 0.780 |
Why?
|
Epithelium, Corneal | 2 | 2022 | 246 | 0.720 |
Why?
|
Corneal Diseases | 1 | 2022 | 535 | 0.520 |
Why?
|
Interleukin-12 | 6 | 1999 | 579 | 0.340 |
Why?
|
Anemia, Sickle Cell | 3 | 2023 | 1067 | 0.300 |
Why?
|
Lentivirus | 3 | 2024 | 518 | 0.300 |
Why?
|
Hematopoietic Stem Cell Mobilization | 2 | 2019 | 227 | 0.290 |
Why?
|
X-Linked Combined Immunodeficiency Diseases | 2 | 2018 | 24 | 0.270 |
Why?
|
Receptors, IgE | 3 | 1999 | 374 | 0.250 |
Why?
|
Cell Transplantation | 2 | 2022 | 473 | 0.230 |
Why?
|
Interferon-gamma | 5 | 1999 | 3160 | 0.230 |
Why?
|
Anemia, Diamond-Blackfan | 1 | 2024 | 147 | 0.210 |
Why?
|
GATA1 Transcription Factor | 1 | 2024 | 306 | 0.210 |
Why?
|
Transplantation, Autologous | 4 | 2022 | 2120 | 0.210 |
Why?
|
Hemoglobin, Sickle | 1 | 2023 | 114 | 0.210 |
Why?
|
Wiskott-Aldrich Syndrome | 1 | 2023 | 131 | 0.210 |
Why?
|
Genetic Vectors | 5 | 2024 | 3404 | 0.210 |
Why?
|
Amniotic Fluid | 3 | 2011 | 380 | 0.200 |
Why?
|
Hydroxyurea | 1 | 2023 | 284 | 0.200 |
Why?
|
T-Lymphocytes | 8 | 2024 | 10261 | 0.190 |
Why?
|
Fetal Hemoglobin | 2 | 2023 | 348 | 0.190 |
Why?
|
Hematopoietic Stem Cells | 7 | 2024 | 3401 | 0.190 |
Why?
|
Eczema | 1 | 2023 | 246 | 0.180 |
Why?
|
Peripheral Blood Stem Cell Transplantation | 2 | 2019 | 266 | 0.180 |
Why?
|
Radiation-Sensitizing Agents | 1 | 2022 | 347 | 0.180 |
Why?
|
Leukocyte Elastase | 1 | 2021 | 113 | 0.170 |
Why?
|
gamma-Globins | 1 | 2020 | 105 | 0.170 |
Why?
|
Cord Blood Stem Cell Transplantation | 2 | 2013 | 316 | 0.160 |
Why?
|
Fanconi Anemia | 1 | 2022 | 327 | 0.160 |
Why?
|
Membrane Glycoproteins | 3 | 2002 | 3690 | 0.160 |
Why?
|
Multigene Family | 1 | 2002 | 1080 | 0.160 |
Why?
|
Granulomatous Disease, Chronic | 1 | 2020 | 176 | 0.160 |
Why?
|
Interleukin-2 | 2 | 1996 | 1896 | 0.160 |
Why?
|
Neuronal Ceroid-Lipofuscinoses | 1 | 2019 | 134 | 0.150 |
Why?
|
Mesenchymal Stem Cells | 4 | 2017 | 1663 | 0.150 |
Why?
|
Chromosomes, Human, X | 1 | 2020 | 319 | 0.140 |
Why?
|
Antigens, CD | 4 | 2024 | 4025 | 0.140 |
Why?
|
Blood Component Removal | 1 | 2018 | 124 | 0.140 |
Why?
|
Heterocyclic Compounds | 1 | 2018 | 245 | 0.140 |
Why?
|
Monokines | 2 | 1999 | 71 | 0.140 |
Why?
|
Graft Survival | 3 | 2019 | 3890 | 0.140 |
Why?
|
Mutagenesis, Insertional | 1 | 2019 | 661 | 0.140 |
Why?
|
Cells, Cultured | 10 | 2022 | 18973 | 0.140 |
Why?
|
Oligonucleotides, Antisense | 1 | 2019 | 462 | 0.130 |
Why?
|
ATP-Binding Cassette Transporters | 2 | 2017 | 568 | 0.130 |
Why?
|
Hydroxamic Acids | 1 | 2019 | 483 | 0.130 |
Why?
|
Down-Regulation | 3 | 2020 | 2927 | 0.130 |
Why?
|
Immunotherapy, Adoptive | 2 | 2024 | 1510 | 0.130 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2021 | 622 | 0.130 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 2 | 2014 | 326 | 0.130 |
Why?
|
Rabbits | 1 | 2022 | 4734 | 0.120 |
Why?
|
Monocytes | 4 | 1999 | 2595 | 0.120 |
Why?
|
Neutropenia | 1 | 2021 | 893 | 0.120 |
Why?
|
Adrenoleukodystrophy | 1 | 2017 | 147 | 0.120 |
Why?
|
Leukocytes, Mononuclear | 2 | 1999 | 1857 | 0.120 |
Why?
|
Gammaretrovirus | 1 | 2014 | 24 | 0.120 |
Why?
|
Interleukin-7 | 1 | 1995 | 147 | 0.120 |
Why?
|
Tissue Engineering | 3 | 2011 | 1855 | 0.120 |
Why?
|
Hematopoietic Stem Cell Transplantation | 3 | 2024 | 5753 | 0.120 |
Why?
|
Metformin | 1 | 2022 | 904 | 0.120 |
Why?
|
Disease Susceptibility | 1 | 2021 | 1789 | 0.110 |
Why?
|
Neuroblastoma | 1 | 2022 | 1263 | 0.110 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2019 | 777 | 0.110 |
Why?
|
Rare Diseases | 1 | 2019 | 635 | 0.110 |
Why?
|
Antigens, CD34 | 4 | 2020 | 656 | 0.110 |
Why?
|
Membrane Transport Proteins | 1 | 2019 | 1028 | 0.110 |
Why?
|
16,16-Dimethylprostaglandin E2 | 1 | 2013 | 22 | 0.110 |
Why?
|
Epithelial Cells | 2 | 2023 | 3681 | 0.110 |
Why?
|
Stem Cell Transplantation | 1 | 2022 | 1602 | 0.110 |
Why?
|
Receptors, Antigen, T-Cell | 3 | 1998 | 2570 | 0.110 |
Why?
|
Drosophila Proteins | 1 | 2002 | 1697 | 0.100 |
Why?
|
Receptors, Cell Surface | 1 | 2002 | 2817 | 0.100 |
Why?
|
Carrier Proteins | 3 | 1999 | 4913 | 0.100 |
Why?
|
RNA Interference | 1 | 2020 | 2832 | 0.100 |
Why?
|
Cell Culture Techniques | 1 | 2019 | 1652 | 0.100 |
Why?
|
Apoptosis | 5 | 2014 | 9514 | 0.090 |
Why?
|
Organometallic Compounds | 1 | 2014 | 644 | 0.090 |
Why?
|
Flow Cytometry | 5 | 2014 | 5881 | 0.090 |
Why?
|
Galectin 1 | 1 | 2011 | 128 | 0.080 |
Why?
|
Regenerative Medicine | 1 | 2013 | 303 | 0.080 |
Why?
|
Repressor Proteins | 1 | 2020 | 2968 | 0.080 |
Why?
|
Mouth Mucosa | 1 | 2012 | 432 | 0.080 |
Why?
|
Immunity, Cellular | 1 | 1995 | 1555 | 0.080 |
Why?
|
Research Support as Topic | 1 | 2014 | 696 | 0.080 |
Why?
|
Suppressor of Cytokine Signaling Proteins | 1 | 2010 | 178 | 0.080 |
Why?
|
Bone Marrow Cells | 1 | 2017 | 2412 | 0.080 |
Why?
|
Cell Transformation, Viral | 1 | 2011 | 527 | 0.080 |
Why?
|
Diaphragm | 1 | 2011 | 356 | 0.080 |
Why?
|
Fetal Blood | 2 | 2013 | 1369 | 0.080 |
Why?
|
Humans | 44 | 2024 | 765968 | 0.080 |
Why?
|
Dinoprostone | 1 | 2011 | 591 | 0.070 |
Why?
|
Program Development | 1 | 2014 | 1295 | 0.070 |
Why?
|
Hematologic Neoplasms | 2 | 2024 | 1927 | 0.070 |
Why?
|
Lymphoproliferative Disorders | 1 | 2011 | 526 | 0.070 |
Why?
|
RNA, Small Interfering | 2 | 2020 | 3421 | 0.070 |
Why?
|
Bone Marrow | 1 | 2017 | 2921 | 0.070 |
Why?
|
T-Lymphocytes, Cytotoxic | 2 | 2011 | 1801 | 0.070 |
Why?
|
Tendons | 1 | 2011 | 555 | 0.070 |
Why?
|
Animals | 15 | 2024 | 168764 | 0.070 |
Why?
|
Bioprosthesis | 1 | 2011 | 589 | 0.070 |
Why?
|
Killer Cells, Natural | 1 | 1995 | 2210 | 0.060 |
Why?
|
Fluorescent Dyes | 1 | 2014 | 1930 | 0.060 |
Why?
|
Mesenchymal Stem Cell Transplantation | 1 | 2011 | 504 | 0.060 |
Why?
|
Mice | 8 | 2024 | 81819 | 0.060 |
Why?
|
Dendritic Cells | 3 | 2010 | 2747 | 0.060 |
Why?
|
Herpesvirus 4, Human | 1 | 2011 | 1078 | 0.060 |
Why?
|
Antigens, CD7 | 1 | 2024 | 30 | 0.060 |
Why?
|
Anti-Bacterial Agents | 1 | 2023 | 7478 | 0.060 |
Why?
|
Lymphocyte Activation | 1 | 1995 | 5501 | 0.060 |
Why?
|
Models, Animal | 1 | 2011 | 2120 | 0.060 |
Why?
|
Cryopreservation | 3 | 2017 | 728 | 0.060 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 2 | 2018 | 813 | 0.060 |
Why?
|
Transcription Factors | 2 | 2023 | 12131 | 0.050 |
Why?
|
Gene Expression Profiling | 2 | 2017 | 9525 | 0.050 |
Why?
|
HIV | 1 | 2010 | 1585 | 0.050 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 1994 | 4348 | 0.050 |
Why?
|
Cytokines | 4 | 2021 | 7421 | 0.050 |
Why?
|
Gene Expression Regulation | 2 | 2024 | 11888 | 0.050 |
Why?
|
Wiskott-Aldrich Syndrome Protein | 1 | 2023 | 163 | 0.050 |
Why?
|
Proto-Oncogene Proteins | 1 | 1995 | 4520 | 0.050 |
Why?
|
Blood Platelets | 1 | 2013 | 2464 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 2 | 2022 | 1410 | 0.050 |
Why?
|
Immunophenotyping | 2 | 2018 | 1866 | 0.050 |
Why?
|
3-Iodobenzylguanidine | 1 | 2022 | 113 | 0.050 |
Why?
|
Fibroblasts | 1 | 2012 | 4159 | 0.050 |
Why?
|
INDEL Mutation | 1 | 2022 | 268 | 0.050 |
Why?
|
Colony-Forming Units Assay | 2 | 2012 | 351 | 0.050 |
Why?
|
Hematopoiesis | 2 | 2023 | 2058 | 0.050 |
Why?
|
Gene Silencing | 2 | 2020 | 1505 | 0.050 |
Why?
|
Erythropoiesis | 1 | 2024 | 691 | 0.040 |
Why?
|
Mitochondria | 1 | 2014 | 3673 | 0.040 |
Why?
|
Clone Cells | 1 | 2023 | 1672 | 0.040 |
Why?
|
Biopsy | 2 | 2023 | 6763 | 0.040 |
Why?
|
Chromones | 1 | 1999 | 148 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 1 | 2021 | 18071 | 0.040 |
Why?
|
Receptors, Vitronectin | 1 | 1999 | 49 | 0.040 |
Why?
|
Thrombospondins | 1 | 1999 | 197 | 0.040 |
Why?
|
GATA2 Transcription Factor | 1 | 2019 | 158 | 0.040 |
Why?
|
Genes, Regulator | 1 | 2020 | 373 | 0.040 |
Why?
|
Toll-Like Receptors | 1 | 2002 | 583 | 0.040 |
Why?
|
Clinical Trials as Topic | 1 | 2014 | 8041 | 0.040 |
Why?
|
Immune Tolerance | 2 | 1998 | 2324 | 0.040 |
Why?
|
CD40 Ligand | 2 | 1998 | 528 | 0.040 |
Why?
|
Commerce | 1 | 2023 | 611 | 0.040 |
Why?
|
Complementarity Determining Regions | 1 | 2018 | 154 | 0.040 |
Why?
|
Signal Transduction | 2 | 2019 | 23601 | 0.040 |
Why?
|
Immunoglobulin Fab Fragments | 1 | 1999 | 445 | 0.040 |
Why?
|
Child | 6 | 2022 | 80564 | 0.040 |
Why?
|
Androstadienes | 1 | 1999 | 347 | 0.040 |
Why?
|
Interleukin-15 | 1 | 1998 | 186 | 0.040 |
Why?
|
Amniocentesis | 2 | 2008 | 116 | 0.040 |
Why?
|
Drugs, Investigational | 1 | 2019 | 211 | 0.040 |
Why?
|
Benzylamines | 1 | 2018 | 251 | 0.040 |
Why?
|
Lipopolysaccharides | 2 | 2010 | 2216 | 0.030 |
Why?
|
Virulence | 1 | 2021 | 1289 | 0.030 |
Why?
|
Caspases | 1 | 1999 | 880 | 0.030 |
Why?
|
Antigens, Neoplasm | 1 | 2024 | 2002 | 0.030 |
Why?
|
Cell Division | 2 | 2018 | 4475 | 0.030 |
Why?
|
Morpholines | 1 | 1999 | 577 | 0.030 |
Why?
|
Feasibility Studies | 2 | 2023 | 5302 | 0.030 |
Why?
|
Pilot Projects | 2 | 2020 | 8733 | 0.030 |
Why?
|
Gene Knockdown Techniques | 1 | 2020 | 1599 | 0.030 |
Why?
|
Fetus | 1 | 2023 | 1870 | 0.030 |
Why?
|
Phylogeny | 1 | 2023 | 2832 | 0.030 |
Why?
|
Interphase | 1 | 1996 | 226 | 0.030 |
Why?
|
Enterotoxins | 1 | 1997 | 366 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 2019 | 1837 | 0.030 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2017 | 633 | 0.030 |
Why?
|
Interleukin Receptor Common gamma Subunit | 1 | 2014 | 89 | 0.030 |
Why?
|
Neoplasms | 1 | 2023 | 22340 | 0.030 |
Why?
|
United States Food and Drug Administration | 2 | 2014 | 1672 | 0.030 |
Why?
|
Erythrocytes | 1 | 2023 | 2395 | 0.030 |
Why?
|
Mice, SCID | 1 | 2019 | 2630 | 0.030 |
Why?
|
Oligopeptides | 1 | 1999 | 1192 | 0.030 |
Why?
|
Forms and Records Control | 1 | 2014 | 158 | 0.030 |
Why?
|
HLA-DR Antigens | 1 | 1995 | 608 | 0.030 |
Why?
|
Young Adult | 4 | 2022 | 59889 | 0.030 |
Why?
|
Antigen-Presenting Cells | 1 | 1997 | 962 | 0.030 |
Why?
|
Adjuvants, Immunologic | 1 | 1998 | 995 | 0.030 |
Why?
|
Coculture Techniques | 2 | 2012 | 1336 | 0.030 |
Why?
|
Keratin-3 | 1 | 2012 | 4 | 0.030 |
Why?
|
Ligands | 2 | 1998 | 3273 | 0.030 |
Why?
|
Child, Preschool | 3 | 2021 | 42500 | 0.030 |
Why?
|
Transplantation Conditioning | 1 | 2020 | 1635 | 0.030 |
Why?
|
Host-Pathogen Interactions | 1 | 2021 | 1461 | 0.030 |
Why?
|
Cell Proliferation | 3 | 2014 | 10429 | 0.020 |
Why?
|
Cell Separation | 2 | 2008 | 1718 | 0.020 |
Why?
|
Recurrence | 1 | 2024 | 8501 | 0.020 |
Why?
|
Adult | 7 | 2024 | 223044 | 0.020 |
Why?
|
Transduction, Genetic | 1 | 2014 | 898 | 0.020 |
Why?
|
Drug Discovery | 1 | 2019 | 1064 | 0.020 |
Why?
|
Tissue Culture Techniques | 1 | 2012 | 286 | 0.020 |
Why?
|
Mutation | 3 | 2023 | 30198 | 0.020 |
Why?
|
Cell Communication | 1 | 1998 | 1660 | 0.020 |
Why?
|
Cell Shape | 1 | 2012 | 373 | 0.020 |
Why?
|
Amnion | 1 | 2012 | 204 | 0.020 |
Why?
|
DNA, Complementary | 1 | 2014 | 1984 | 0.020 |
Why?
|
Dermis | 1 | 2012 | 204 | 0.020 |
Why?
|
Transgenes | 1 | 2014 | 1015 | 0.020 |
Why?
|
Antibodies, Monoclonal | 3 | 2011 | 9249 | 0.020 |
Why?
|
3T3 Cells | 1 | 2012 | 1081 | 0.020 |
Why?
|
Adolescent | 4 | 2020 | 88835 | 0.020 |
Why?
|
Transplantation Chimera | 1 | 2013 | 609 | 0.020 |
Why?
|
Interleukin-1 | 1 | 1994 | 1243 | 0.020 |
Why?
|
RNA, Messenger | 2 | 2019 | 12768 | 0.020 |
Why?
|
Osteogenesis | 1 | 2017 | 1282 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 1999 | 1884 | 0.020 |
Why?
|
United States | 5 | 2020 | 72903 | 0.020 |
Why?
|
Product Surveillance, Postmarketing | 1 | 2014 | 464 | 0.020 |
Why?
|
HLA-A Antigens | 1 | 2010 | 223 | 0.020 |
Why?
|
HLA-A2 Antigen | 1 | 2010 | 207 | 0.020 |
Why?
|
Hernia, Diaphragmatic | 1 | 2011 | 243 | 0.020 |
Why?
|
Polytetrafluoroethylene | 1 | 2011 | 238 | 0.020 |
Why?
|
Viral Matrix Proteins | 1 | 2011 | 192 | 0.020 |
Why?
|
Cell Line, Transformed | 1 | 2011 | 858 | 0.020 |
Why?
|
Staining and Labeling | 1 | 2014 | 1072 | 0.020 |
Why?
|
Transcription Factor AP-1 | 1 | 2011 | 322 | 0.020 |
Why?
|
Male | 7 | 2024 | 363698 | 0.020 |
Why?
|
Staphylococcus aureus | 1 | 1997 | 1424 | 0.020 |
Why?
|
Enzyme Inhibitors | 1 | 1999 | 3715 | 0.020 |
Why?
|
Gestational Age | 2 | 2008 | 3609 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2020 | 5786 | 0.020 |
Why?
|
Primates | 1 | 2011 | 518 | 0.020 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 1999 | 1646 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2017 | 6069 | 0.020 |
Why?
|
Sheep | 1 | 2011 | 1440 | 0.020 |
Why?
|
Phagocytosis | 1 | 2014 | 1520 | 0.020 |
Why?
|
Child Development | 1 | 2019 | 2327 | 0.020 |
Why?
|
Female | 8 | 2024 | 396112 | 0.020 |
Why?
|
Protein Binding | 1 | 1999 | 9296 | 0.020 |
Why?
|
Adiposity | 1 | 2017 | 1890 | 0.020 |
Why?
|
Neutrophils | 1 | 2020 | 3776 | 0.020 |
Why?
|
Eye Diseases | 1 | 2012 | 659 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2019 | 9550 | 0.020 |
Why?
|
Seizures | 1 | 2019 | 3000 | 0.020 |
Why?
|
Neuropsychological Tests | 1 | 2019 | 7123 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2018 | 10729 | 0.020 |
Why?
|
Serum | 1 | 2007 | 206 | 0.020 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 1998 | 4405 | 0.020 |
Why?
|
Skin | 1 | 2019 | 4489 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2017 | 8529 | 0.020 |
Why?
|
Myeloid Cells | 1 | 2010 | 839 | 0.020 |
Why?
|
Data Collection | 1 | 2014 | 3318 | 0.020 |
Why?
|
Treatment Outcome | 3 | 2020 | 65188 | 0.020 |
Why?
|
Comorbidity | 1 | 2020 | 10563 | 0.020 |
Why?
|
Culture Media | 1 | 2007 | 890 | 0.010 |
Why?
|
Transplantation, Homologous | 1 | 2013 | 4860 | 0.010 |
Why?
|
Interleukin-6 | 1 | 1994 | 3222 | 0.010 |
Why?
|
Cell Line | 2 | 2014 | 15543 | 0.010 |
Why?
|
Electroencephalography | 1 | 2019 | 6273 | 0.010 |
Why?
|
Specimen Handling | 1 | 2008 | 704 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 4562 | 0.010 |
Why?
|
Blotting, Western | 1 | 2010 | 5020 | 0.010 |
Why?
|
Species Specificity | 1 | 2007 | 2406 | 0.010 |
Why?
|
Transplantation, Heterologous | 1 | 2011 | 2394 | 0.010 |
Why?
|
Internet | 1 | 2014 | 3106 | 0.010 |
Why?
|
Gene Expression | 1 | 2014 | 7584 | 0.010 |
Why?
|
Up-Regulation | 1 | 2011 | 4137 | 0.010 |
Why?
|
Guidelines as Topic | 1 | 2008 | 1394 | 0.010 |
Why?
|
Cattle | 1 | 2007 | 3801 | 0.010 |
Why?
|
Neoplasm Proteins | 1 | 2012 | 3596 | 0.010 |
Why?
|
Integrin alphaV | 1 | 1999 | 54 | 0.010 |
Why?
|
Biomedical Research | 1 | 2014 | 3458 | 0.010 |
Why?
|
Databases, Factual | 1 | 2014 | 8067 | 0.010 |
Why?
|
Macrophages | 1 | 2014 | 5772 | 0.010 |
Why?
|
Aged | 3 | 2024 | 171117 | 0.010 |
Why?
|
Cell Survival | 1 | 2008 | 5747 | 0.010 |
Why?
|
Peptide Fragments | 1 | 2010 | 5125 | 0.010 |
Why?
|
Pregnancy | 2 | 2011 | 30260 | 0.010 |
Why?
|
Middle Aged | 3 | 2024 | 223009 | 0.010 |
Why?
|
Solubility | 1 | 1999 | 1078 | 0.010 |
Why?
|
Mitogens | 1 | 1997 | 228 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2012 | 7851 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2011 | 8611 | 0.010 |
Why?
|
Injections, Intravenous | 1 | 1997 | 1377 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2011 | 17075 | 0.010 |
Why?
|
Interleukin-10 | 1 | 1998 | 1183 | 0.010 |
Why?
|
Antigens | 1 | 1998 | 1438 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2008 | 14652 | 0.010 |
Why?
|
Cell Count | 1 | 1997 | 1823 | 0.010 |
Why?
|
Infant | 1 | 2014 | 36386 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2011 | 18293 | 0.010 |
Why?
|
Spleen | 1 | 1997 | 2296 | 0.010 |
Why?
|
Transforming Growth Factor beta | 1 | 1998 | 1995 | 0.010 |
Why?
|
Phenotype | 1 | 2007 | 16721 | 0.000 |
Why?
|
Mice, Inbred BALB C | 1 | 1997 | 6220 | 0.000 |
Why?
|
Transcription, Genetic | 1 | 1998 | 7599 | 0.000 |
Why?
|
HIV Infections | 1 | 2010 | 17533 | 0.000 |
Why?
|